This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Congress, Industry Urge NOAA To Support Bluefin Tuna Fishery; Scientists Call Pew Trust "factsheet" A Distortion

WASHINGTON, June 25, 2013 /PRNewswire/ -- ( Saving Seafood) -- Ten Members of Congress asked negotiators to pursue increased U.S. allocation of bluefin tuna at an international meeting this week. Meanwhile, the Pew Charitable Trusts argued for stricter limits in a "factsheet" that leading scientists called an "irresponsible distortion of the information available." American fishermen felt betrayed by U.S. negotiators in the past, who they argue sided with conservation groups over domestic fisheries and sound science.

The International Commission for the Conservation of Atlantic Tunas (ICCAT) convenes Wednesday in Montreal to discuss the Atlantic bluefin tuna stock assessment. Lawmakers asked delegation chief Russell Smith to "pursue all possible means to secure an increase in the [Total Allowable Catch] for the western Atlantic bluefin tuna stock," declaring current allocations "insufficient to sustain our traditional and valuable U.S. fisheries."

Industry members agreed. "Positions advanced by U.S. negotiators at ICCAT have ignored the interests of our American fishermen," stated Ernie Panacek, President of the Blue Water Fishermen's Association. "As a result, valuable U.S. fisheries, including bluefin tuna and swordfish, are being strangled by our own government."

Pew sent ICCAT a "factsheet" calling positions they support the " best available science," and dismissing as "unsupported" several theories considered valid by ICCAT that remain the subject of continuing scientific debate.

Four senior fisheries scientists from the University of Massachusetts and the University of Maine, including the president of the American Institute of Fishery Research Biologists, issued a rebuttal of Pew's "factsheet," saying it "lacks scientific credibility." They noted that scientific understanding of bluefin tuna remains "highly uncertain," that "many aspects of Atlantic bluefin tuna biology are not known definitively, and that alternative hypotheses should be considered by scientists and fisheries managers."

The discrepancy is rooted in two competing population models: a "high" and "low" scenario. The "high" model predicts that the bluefin population should be much larger than it currently is, suggesting that severe catch reductions are in order. The "low" model estimates the natural population at levels close to those currently seen, suggesting that the current catch levels can be maintained or increased.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs